NCT00402259

Efficacy and Safety Study of Esomeprazole vs Omeprazole to Treat Acute Non-Variceal Upper Gastrointestinal Bleeding

A Randomised, Double-Blind, Double-Dummy, Active-Controlled, Multicenter Study to Assess the Efficacy and Safety of Esomeprazole or Omeprazole for 5 Days in Subjects With Acute Non-Variceal Upper Gastrointestinal Bleeding

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 440 (estimated)
• Sponsor: AstraZeneca · Industry
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to assess the efficacy and safety of Esomeprazole and Omeprazole intravenous every 12 hours for 5 days in subjects with acute non-variceal upper gastrointestinal bleeding

Conditions

• Gastrointestinal Hemorrhage

Interventions

Type	Name	Description
DRUG	Esomeprazole IV
DRUG	Omeprazole IV

Timeline

• Start date: 2006-08-01
• Completion: 2007-10-01
• First posted: 2006-11-22
• Last updated: 2009-03-12

Locations

7 sites across 1 country: China